Publications and Innovation
October 2016 – Published in the peer-reviewed journal, Proceedings in Obstetrics and Gynecology, the authors present a clinical treatment protocol for testing women early in pregnancy with a validated biomarker test for preterm birth risk, and administering recommended interventions based on a woman’s individual risk. The paper, Preterm Birth: can we do better? discusses:
May 2016 – This study, published as an Editor’s Choice article in the May issue of American Journal of Obstetrics & Gynecology, concluded that a serum-based molecular predictor (the PreTRM test) predicts an asymptomatic pregnant woman’s individual risk of spontaneous preterm delivery. This information, early in her pregnancy, may provide clinical utility in identifying women at increased risk at an early stage of pregnancy and allowing for clinical intervention that may help prolong gestational age and improve neonatal outcome.
May 2016 – Published in Contemporary OB/GYN, this supplement captured proceedings of a panel discussion hosted by Sera Prognostics at the 2016 Society of Maternal-Fetal Medicine Annual meeting.
March 2016 - Sera Prognostics, Inc. presented data demonstrating correlation between ELISA and MRM-MS at the Society of Reproductive Investigation 2016 Annual Meeting. The results of the data demonstrated a two protein ELISA platform that is highly correlative with LC-MRM-MS results and generates sPTB risk scores with excellent classification performance.
February 2016 - PAPR investigators presented the findings of the landmark PAPR study at the 2016 Society of Maternal-Fetal Medicine meeting. The conclusions of the study and resulting American Journal of Obstetrics & Gynecology was that a serum-based molecular predictor identifies asymptomatic pregnant women at risk of spontaneous preterm delivery, which may provide utility in identifying women at risk at an early stage of pregnancy to allow for clinical intervention.
March 2015 - Sera Prognostics, Inc. presented data demonstrating correlation between ELISA and MRM-MS at the Society of Reproductive Investigation 2015 Annual Meeting.